<![CDATA[EU/3/16/1754 (Lutetium-177(3+),S2,S7-cyclo[N-{4,7,10-tricarboxymethyl-1,4,7,10-tetraaza-cyclododecan-1-yl-acetyl}-4-chloro-L-phenylalanyl-D-cysteinyl-4-[(4S)-2,6-dioxo-1,3-diazinane-4-carboxamido]-L-phenylalanyl-4-(carbamoylamino)-D-phenylalanyl-L-lysyl-L-threonyl-L-cysteinyl-D-tyrosinamide])

<![CDATA[EU/3/16/1754 (Lutetium-177(3+),S2,S7-cyclo[N-{4,7,10-tricarboxymethyl-1,4,7,10-tetraaza-cyclododecan-1-yl-acetyl}-4-chloro-L-phenylalanyl-D-cysteinyl-4-[(4S)-2,6-dioxo-1,3-diazinane-4-carboxamido]-L-phenylalanyl-4-(carbamoylamino)-D-phenylalanyl-L-lysyl-L-threonyl-L-cysteinyl-D-tyrosinamide]) - Ipsen Pharma]]> 1440 Copyright: (C) European Commission en-gb Tue, 18 Oct 2016 12:10:00 +0000 http://ec.europa.eu/health/documents/community-register/html/o1754.htm 2,S⁷-cyclo[N-{4,7,10-tricarboxymethyl-1,4,7,10-tetraaza-cyclododecan-1-yl-acetyl}-4-chloro-L-phenylalanyl-D-cysteinyl-4-[(4S)-2,6-dioxo-1,3-diazinane-4-carboxamido]-L-phenylalanyl-4-(carbamoylamino)-D-phenylalanyl-L-lysyl-L-threonyl-L-cysteinyl-D-tyrosinamide]) - EU number: EU/3/16/1754 - Marketing authorisation holder: Ipsen Pharma]]> <![CDATA[EU/3/16/1754 (Lutetium-177(3+),S2,S7-cyclo[N-{4,7,10-tricarboxymethyl-1,4,7,10-tetraaza-cyclododecan-1-yl-acetyl}-4-chloro-L-phenylalanyl-D-cysteinyl-4-[(4S)-2,6-dioxo-1,3-diazinane-4-carboxamido]-L-phenylalanyl-4-(carbamoylamino)-D-phenylalanyl-L-lysyl-L-threonyl-L-cysteinyl-D-tyrosinamide]) - Ipsen Pharma]]> http://ec.europa.eu/health/documents/community-register/images/logo_en.gif http://ec.europa.eu/health/documents/community-register/html/o1754.htm 144 100 Orphan designation - Commission Decision (2016)6745 of Tue, 18 Oct 2016 New documents http://ec.europa.eu/health/documents/community-register/html/o1754.htm#proc136143 http://ec.europa.eu/health/documents/community-register/html/o1754.htm#proc136143 Tue, 18 Oct 2016 12:10:00 +0000